Webinars Live and recorded scientific educational resources presented by industry thought leaders... LBS Clinical Solutions Content 임상 진단 솔루션 염색 사전 분석 및 검체 준비 검체 처리 디지털 병리 웨비나 사례 연구 리소스 Fast Forward to Next Generation Imaging - The Leica Biosystems Solution Bringing Your Digital Pathology to the Next Level. Mark Green Sara van den Boomen , Digital Pathology Sales Specialist, UK The Cutting-Edge Technology of AI Prostate Cancer Diagnosis in the Era of Digital Pathology Mr. Sunwoo Kim , PhD Digital Pathology for Primary Diagnosis from an IT Manager's perspective Mark Flood, BMLSc , Application Specialist, Pathology Associates, Pathlab Bay of Plenty, New Zealand How Integration Helps to Adopt Digital Pathology Prof. Dr. Peter Schüffler, PhD Demystifying DICOM in Digital Pathology: Experiences from the National Pathology Imaging Co-operative Dr Craig Sayers, MD Experience Next Generation Imaging - Leica Biosystems latest Digital Pathology solution built with pathologist in mind Sai Ram Prakash Chandrasekaran COVID-19 Response and the (Remote) Use of Digital Pathology Lance Mikus , MBA The Value of an RTUThe Value of an RTU Novocastra p16 Antibody Demonstrated an Agreement of 98% with the Roche p16 Antibody Dr. Selvam Thavaraj , PhD FDSRCS FRCPath Novocastra p16 antibody demonstrated an agreement of 98% with the Roche p16 antibody The study compared the percentage agreement rates of Novocastra’s p16 (6H12) IVD solution with Roche CINtec® Histology p16 assay on 170 oropharyngeal cancer cases. How to dramatically reduce your IHC staining times with the Leica Biosystems BOND-IIINEW STUDY SHOWS BOND-III UP TO 40% FASTER THAN BENCHMARK ULTRA In a recent study, the Leica Biosystems BOND-III was found to complete cases up to 100 minutes faster than the Roche Tissue Diagnostics BenchMark ULTRA. The study examines the panel turnaround...
